Growing community of inventors

Parma, Italy

Francesca Schiaretti

Average Co-Inventor Count = 3.53

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 16

Francesca SchiarettiClaudio Cafiero (4 patents)Francesca SchiarettiLeonardo Ortenzi (4 patents)Francesca SchiarettiFausto Pivetti (2 patents)Francesca SchiarettiRossella Musa (2 patents)Francesca SchiarettiIrene Pasquali (2 patents)Francesca SchiarettiDaniela Cocconi (2 patents)Francesca SchiarettiRuggero Bettini (2 patents)Francesca SchiarettiRoberto Bilzi (2 patents)Francesca SchiarettiAndrea Benassi (2 patents)Francesca SchiarettiFrancesca Buttini (2 patents)Francesca SchiarettiAlessandro Cavecchi (2 patents)Francesca SchiarettiCristiana Merusi (2 patents)Francesca SchiarettiEnrico Salomi (2 patents)Francesca SchiarettiAzita Askey-Sarvar (2 patents)Francesca SchiarettiMassimiliano Dagli Alberi (1 patent)Francesca SchiarettiAndrea Busca (1 patent)Francesca SchiarettiFrancesca Schiaretti (12 patents)Claudio CafieroClaudio Cafiero (8 patents)Leonardo OrtenziLeonardo Ortenzi (7 patents)Fausto PivettiFausto Pivetti (18 patents)Rossella MusaRossella Musa (17 patents)Irene PasqualiIrene Pasquali (9 patents)Daniela CocconiDaniela Cocconi (9 patents)Ruggero BettiniRuggero Bettini (8 patents)Roberto BilziRoberto Bilzi (5 patents)Andrea BenassiAndrea Benassi (3 patents)Francesca ButtiniFrancesca Buttini (3 patents)Alessandro CavecchiAlessandro Cavecchi (2 patents)Cristiana MerusiCristiana Merusi (2 patents)Enrico SalomiEnrico Salomi (2 patents)Azita Askey-SarvarAzita Askey-Sarvar (2 patents)Massimiliano Dagli AlberiMassimiliano Dagli Alberi (3 patents)Andrea BuscaAndrea Busca (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Chiesi Farmaceutici S.p.a. (12 from 329 patents)


12 patents:

1. 11628175 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

2. 10966991 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

3. 10786450 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

4. 10772896 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

5. 10709666 - Carrier particles for dry powder formulations for inhalation

6. 10583085 - Carrier particles for dry powder formulations for inhalation

7. 10350164 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

8. 10086004 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

9. 9808422 - Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation

10. 9402825 - Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation

11. 9308200 - Dry powder formulation comprising a phosphodiesterase inhibitor

12. 9132121 - Dry powder formulation comprising a phosphodiesterase inhibitor

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/15/2025
Loading…